Скачать клипы Digital ILC 2020 session: NAFLD ↓

Digital ILC 2020 session: NAFLD - Target identification and drug pipeline

Digital ILC 2020 session: NAFLD - Target identification and drug pipeline

Digital ILC 2020 abstract session: NAFLD - Experimental

Digital ILC 2020 abstract session: NAFLD - Experimental

Digital ILC 2020 - Immunity & HCC abstract session

Digital ILC 2020 - Immunity & HCC abstract session

Digital ILC 2020. Immune-mediated and chronic cholestatic liver disease - Clinical aspects.

Digital ILC 2020. Immune-mediated and chronic cholestatic liver disease - Clinical aspects.

Digital ILC 2020 General Session 1

Digital ILC 2020 General Session 1

Cirrhosis and Complications Digital ILC 2020

Cirrhosis and Complications Digital ILC 2020

Digital ILC 2020:Immune-mediated & chronic cholestasic liver disease: Experimental & pathophysiology

Digital ILC 2020:Immune-mediated & chronic cholestasic liver disease: Experimental & pathophysiology

Digital ILC 2020: General session II

Digital ILC 2020: General session II

NAFLD Pharmacological therapy abstract session

NAFLD Pharmacological therapy abstract session

Viral hepatitis abstract session at Digital ILC 2020

Viral hepatitis abstract session at Digital ILC 2020

Digital ILC 2020 - General hepatology: Late-breakers abstracts session

Digital ILC 2020 - General hepatology: Late-breakers abstracts session

Abstract session Liver fibrosis

Abstract session Liver fibrosis

Digital ILC 2020 session: From liver transplantation to systemic therapy in Hepatocellular Carcinoma

Digital ILC 2020 session: From liver transplantation to systemic therapy in Hepatocellular Carcinoma

Welcome to the Digital ILC 2020

Welcome to the Digital ILC 2020

Digital International Liver Congress 2020

Digital International Liver Congress 2020

Explore EASL Campus

Explore EASL Campus

EASL Digital ILC 2020 Wrap-Up: A Complicated Picture Emerges - Ep 24

EASL Digital ILC 2020 Wrap-Up: A Complicated Picture Emerges - Ep 24

NAFLD Summit Program -5th July 2020

NAFLD Summit Program -5th July 2020

EASL Policy Statement on the coexistence of NAFLD and ARLD (Patient Forum 2020)

EASL Policy Statement on the coexistence of NAFLD and ARLD (Patient Forum 2020)

S2-E31.2 - Previewing Digital ILC 2021 -- Part II -- Drug Development

S2-E31.2 - Previewing Digital ILC 2021 -- Part II -- Drug Development

EASL Studio Midday Talks: Steatotic liver disease global consensus to change nomenclature

EASL Studio Midday Talks: Steatotic liver disease global consensus to change nomenclature

EASL Studio S4E12 - NAFLD and NASH – moving beyond the liver biopsy – where are we now?

EASL Studio S4E12 - NAFLD and NASH – moving beyond the liver biopsy – where are we now?

"Liver pancreas cross talk in the context of NAFLD"

"Liver pancreas cross talk in the context of NAFLD"

Dr. Quentin Anstee

Dr. Quentin Anstee

FLF LIVER Webinar Series | Part-One (Highlights from EASL 2020)

FLF LIVER Webinar Series | Part-One (Highlights from EASL 2020)

Скачать клипы Digital ILC 2020 session: NAFLD бесплатно и без регистрации